JP2012051891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012051891A5 JP2012051891A5 JP2011208852A JP2011208852A JP2012051891A5 JP 2012051891 A5 JP2012051891 A5 JP 2012051891A5 JP 2011208852 A JP2011208852 A JP 2011208852A JP 2011208852 A JP2011208852 A JP 2011208852A JP 2012051891 A5 JP2012051891 A5 JP 2012051891A5
- Authority
- JP
- Japan
- Prior art keywords
- supplementary note
- appendix
- growth hormone
- supplementary
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000018997 Growth Hormone Human genes 0.000 claims description 18
- 108010051696 Growth Hormone Proteins 0.000 claims description 18
- 239000000122 growth hormone Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000008363 phosphate buffer Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 description 23
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- -1 NaCl Chemical class 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229940100630 metacresol Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229960003742 phenol Drugs 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9916252.1 | 1999-07-12 | ||
| GBGB9916252.1A GB9916252D0 (en) | 1999-07-12 | 1999-07-12 | Growth hormone formulation |
| GB9918902.9 | 1999-08-12 | ||
| GBGB9918902.9A GB9918902D0 (en) | 1999-08-12 | 1999-08-12 | Growth hormone formulation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509214A Division JP2003504346A (ja) | 1999-07-12 | 2000-07-11 | 成長ホルモン製剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014113773A Division JP5941496B2 (ja) | 1999-07-12 | 2014-06-02 | 成長ホルモン製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012051891A JP2012051891A (ja) | 2012-03-15 |
| JP2012051891A5 true JP2012051891A5 (enExample) | 2012-12-13 |
Family
ID=26315757
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509214A Pending JP2003504346A (ja) | 1999-07-12 | 2000-07-11 | 成長ホルモン製剤 |
| JP2011208852A Pending JP2012051891A (ja) | 1999-07-12 | 2011-09-26 | 成長ホルモン製剤 |
| JP2014113773A Expired - Lifetime JP5941496B2 (ja) | 1999-07-12 | 2014-06-02 | 成長ホルモン製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001509214A Pending JP2003504346A (ja) | 1999-07-12 | 2000-07-11 | 成長ホルモン製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014113773A Expired - Lifetime JP5941496B2 (ja) | 1999-07-12 | 2014-06-02 | 成長ホルモン製剤 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20060029635A1 (enExample) |
| EP (1) | EP1194170B1 (enExample) |
| JP (3) | JP2003504346A (enExample) |
| KR (1) | KR20020031388A (enExample) |
| CN (1) | CN1360506A (enExample) |
| AR (1) | AR024728A1 (enExample) |
| AT (1) | ATE386501T1 (enExample) |
| AU (1) | AU775107C (enExample) |
| BR (1) | BR0013162A (enExample) |
| CA (1) | CA2378949C (enExample) |
| CZ (1) | CZ200260A3 (enExample) |
| DE (1) | DE60038118T2 (enExample) |
| ES (1) | ES2300268T3 (enExample) |
| HK (1) | HK1046358A1 (enExample) |
| HU (1) | HUP0202189A3 (enExample) |
| IL (2) | IL147253A0 (enExample) |
| MX (1) | MXPA02000404A (enExample) |
| NO (1) | NO20020151L (enExample) |
| NZ (1) | NZ516507A (enExample) |
| PL (1) | PL353238A1 (enExample) |
| SI (1) | SI1194170T1 (enExample) |
| SK (1) | SK252002A3 (enExample) |
| TR (1) | TR200200034T2 (enExample) |
| TW (1) | TWI247608B (enExample) |
| WO (1) | WO2001003741A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030162711A1 (en) * | 1996-04-24 | 2003-08-28 | Soren Bjorn | Pharmaceutical formulation |
| US20070179096A1 (en) * | 1996-04-24 | 2007-08-02 | Novo Nordisk A/S | Pharmaceutical Formulation |
| GB2371227A (en) * | 2001-01-10 | 2002-07-24 | Grandis Biotech Gmbh | Crystallisation - resistant aqueous growth hormone formulations |
| AU2003249992A1 (en) * | 2002-07-09 | 2004-01-23 | Sandoz Ag | Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| JP4949828B2 (ja) * | 2003-03-18 | 2012-06-13 | アレス トレーディング ソシエテ アノニム | 溶液中での成長ホルモンの安定化 |
| JP2007506683A (ja) * | 2003-09-25 | 2007-03-22 | カンジェーン コーポレイション | ヒト成長ホルモン剤およびその調整方法と使用方法 |
| US8338374B2 (en) | 2003-12-23 | 2012-12-25 | Pharmacia Corporation | Stable growth hormone liquid formulation |
| UA89781C2 (uk) * | 2004-04-07 | 2010-03-10 | Арес Трейдінг С.А. | Рідкий склад гормона росту |
| US8293532B2 (en) | 2009-03-26 | 2012-10-23 | Dow AgroSciences, L.L.C. | Method and apparatus for tissue transfer |
| EP2501367B1 (en) * | 2009-11-17 | 2015-01-21 | Ipsen Pharma S.A.S. | Formulation for HGH and RHIGF-1 combination |
| US20140194356A1 (en) | 2011-07-25 | 2014-07-10 | Sandoz Ag | Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein |
| US20130288968A1 (en) * | 2012-04-30 | 2013-10-31 | Sun Pharmaceutical Industries Ltd. | Leuprolide injection |
| JP6001401B2 (ja) * | 2012-09-28 | 2016-10-05 | ユニ・チャーム株式会社 | ウェットティッシュ用薬液及びウェットティッシュ |
| JP6179690B1 (ja) | 2015-12-10 | 2017-08-16 | 三菱瓦斯化学株式会社 | 光硬化性組成物及び光学材料 |
| JP6172880B1 (ja) * | 2017-02-01 | 2017-08-02 | 協和発酵キリン株式会社 | ダルベポエチンを含む液体医薬組成物 |
| US11738068B2 (en) | 2018-06-25 | 2023-08-29 | Jcr Pharmaceuticals Co., Ltd. | Protein-containing aqueous liquid formulation |
| AU2021379990A1 (en) * | 2020-11-16 | 2023-06-29 | W. L. Gore & Associates, Inc. | Formulations, methods, and pre-filled multi-dose injection devices without cloud point |
| CN112494638B (zh) * | 2020-12-22 | 2023-12-19 | 深圳科兴药业有限公司 | 一种人生长激素注射剂组合物及其制备方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783441A (en) * | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
| DE3325223A1 (de) * | 1983-07-13 | 1985-01-24 | Hoechst Ag, 6230 Frankfurt | Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung |
| BR8603586A (pt) * | 1985-07-30 | 1987-03-10 | Int Minerals & Chem Corp | Processo para manter a fluidez de um homonio;processo para efetuar a promocao de crescimento em animais e formulacao promotora de crescimento |
| US4857505A (en) * | 1987-03-09 | 1989-08-15 | American Cyanamid Company | Sustained release compositions for parenteral administration and their use |
| IL86799A (en) * | 1987-07-02 | 1993-03-15 | Kabi Pharmacia Ab | Method and device for injection |
| US5151265A (en) * | 1987-11-03 | 1992-09-29 | Genentech, Inc. | Gamma interferon formulation |
| CA1331133C (en) * | 1988-03-01 | 1994-08-02 | Michael Jon Pikal | Pharmaceutical growth hormone formulations |
| US5763394A (en) * | 1988-04-15 | 1998-06-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| JPH0383931A (ja) * | 1989-08-29 | 1991-04-09 | Sumitomo Pharmaceut Co Ltd | 低刺激性ｇｒｆ経鼻投与製剤 |
| US5681814A (en) * | 1990-06-07 | 1997-10-28 | Genentech, Inc. | Formulated IGF-I Composition |
| US5126324A (en) * | 1990-06-07 | 1992-06-30 | Genentech, Inc. | Method of enhancing growth in patients using combination therapy |
| DE69110290T2 (de) * | 1990-09-21 | 1995-10-19 | Novonordisk As | Adaptor. |
| SE9201073D0 (sv) * | 1992-04-03 | 1992-04-03 | Kabi Pharmacia Ab | Protein formulation |
| MD1699F2 (ro) * | 1992-07-31 | 2001-07-31 | Genentech, Inc. | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei |
| US5334162A (en) * | 1993-03-15 | 1994-08-02 | Eli Lilly And Company | Cartridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same |
| US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| US5610134A (en) * | 1994-04-15 | 1997-03-11 | Genentech, Inc. | Treatment of congestive heart failure |
| JPH0892125A (ja) * | 1994-09-21 | 1996-04-09 | Nippon Chem Res Kk | 水性医薬組成物 |
| SE9502927D0 (sv) * | 1995-08-24 | 1995-08-24 | Pharmacia Ab | Solution containing IGF-I |
| AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
| DE69709069T2 (de) * | 1996-02-13 | 2002-07-04 | G.D. Searle & Co., Chicago | Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten |
| ZA9711731B (en) * | 1996-12-31 | 1998-07-01 | Monsanto Co | Aqueous glycerol formulations of somatotropin |
| TW518235B (en) * | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| JP3723857B2 (ja) * | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | ヒト成長ホルモン含有水性医薬組成物 |
-
2000
- 2000-07-11 CA CA2378949A patent/CA2378949C/en not_active Expired - Lifetime
- 2000-07-11 CZ CZ200260A patent/CZ200260A3/cs unknown
- 2000-07-11 HK HK02106653.3A patent/HK1046358A1/zh unknown
- 2000-07-11 BR BR0013162-8A patent/BR0013162A/pt not_active IP Right Cessation
- 2000-07-11 IL IL14725300A patent/IL147253A0/xx not_active IP Right Cessation
- 2000-07-11 AU AU59975/00A patent/AU775107C/en not_active Expired
- 2000-07-11 SI SI200030992T patent/SI1194170T1/sl unknown
- 2000-07-11 ES ES00946088T patent/ES2300268T3/es not_active Expired - Lifetime
- 2000-07-11 MX MXPA02000404A patent/MXPA02000404A/es active IP Right Grant
- 2000-07-11 DE DE60038118T patent/DE60038118T2/de not_active Expired - Lifetime
- 2000-07-11 SK SK25-2002A patent/SK252002A3/sk unknown
- 2000-07-11 NZ NZ516507A patent/NZ516507A/xx unknown
- 2000-07-11 TR TR2002/00034T patent/TR200200034T2/xx unknown
- 2000-07-11 HU HU0202189A patent/HUP0202189A3/hu unknown
- 2000-07-11 PL PL00353238A patent/PL353238A1/xx not_active Application Discontinuation
- 2000-07-11 AT AT00946088T patent/ATE386501T1/de active
- 2000-07-11 EP EP00946088A patent/EP1194170B1/en not_active Expired - Lifetime
- 2000-07-11 WO PCT/GB2000/002664 patent/WO2001003741A1/en not_active Ceased
- 2000-07-11 KR KR1020027000416A patent/KR20020031388A/ko not_active Ceased
- 2000-07-11 JP JP2001509214A patent/JP2003504346A/ja active Pending
- 2000-07-11 CN CN00810174A patent/CN1360506A/zh active Pending
- 2000-07-13 AR ARP000103593A patent/AR024728A1/es unknown
- 2000-08-24 TW TW089117050A patent/TWI247608B/zh not_active IP Right Cessation
-
2001
- 2001-12-24 IL IL147253A patent/IL147253A/en unknown
-
2002
- 2002-01-11 NO NO20020151A patent/NO20020151L/no not_active Application Discontinuation
-
2005
- 2005-10-03 US US11/242,499 patent/US20060029635A1/en not_active Abandoned
-
2011
- 2011-09-26 JP JP2011208852A patent/JP2012051891A/ja active Pending
-
2014
- 2014-06-02 JP JP2014113773A patent/JP5941496B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7093669B2 (ja) | 即効型インスリン組成物 | |
| FI3091029T3 (fi) | Anti-il13-vasta-aineformulaatioita | |
| DK2315581T3 (en) | TOPICAL COMPOSITION FOR THE TREATMENT OF actinic keratosis | |
| EA201492021A1 (ru) | Антительный состав | |
| JP2018138578A5 (enExample) | ||
| JP2014518216A5 (enExample) | ||
| RU2016119746A (ru) | Стабильный состав инсулина глулизин | |
| JP2013543505A5 (enExample) | ||
| AR094821A1 (es) | Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada | |
| MX369201B (es) | Formulación líquida de un conjugado de insulina de acción prolongada. | |
| JP2003504346A5 (enExample) | ||
| JP2013525493A5 (enExample) | ||
| US9636376B2 (en) | Stable compositions of peptide epoxy ketones | |
| CN105246471A (zh) | 外用药物组合物 | |
| FI3528787T3 (fi) | Farmaseuttisia formulaatioita ja menetelmiä niiden valmistamiseksi | |
| JPWO2015190378A1 (ja) | 安定なアダリムマブ水性製剤 | |
| JP6344947B2 (ja) | ロキソプロフェン含有外用固形剤 | |
| JP2018532806A5 (enExample) | ||
| WO2001003741B1 (en) | Growth hormone formulations | |
| JP6394957B2 (ja) | 点眼剤 | |
| TWI658839B (zh) | 治療趾甲黴菌病之局部抗真菌組成物及其用途 | |
| US20210353539A1 (en) | Aqueous Preparation for External Use | |
| US20190240155A1 (en) | Liquid formulations of daptomycin | |
| TW202335664A (zh) | 眼科組成物 | |
| KR20230163502A (ko) | 헤테로시클리덴 아세트아미드 유도체 함유 현탁액 |